Your approach to suppliers needs to be part of your strategic plan since almost every company, whether product- or service-oriented, is dependent on suppliers. Many business owners seem to get this supplier issue backwards. They think that because they write the order, they’re in the dominant position and can exploit it with unreasonable demands, including personal perks.
CIMAB SA is a Cuban biopharmaceutical institute. “Excellence and Confidence …” Since 1992 CIMAB SA is dedicated to the marketing of biopharmaceuticals in the domestic and international markets, especially monoclonal antibodies and other recombinant proteins for the diagnosis and treatment of cancer and other diseases related to the immune system. CIMAB SA is the exclusive representative of the Center of Molecular Immunology (CIM), also represents the “Laboratories AICA” and Plant cytostatic CIDEM for the commercialization of some of its pharmaceutical products. CIMAB SA’s main mission is export of new biological medicines for the treatment of cancer and other chronic and non-transmitted diseases.
Jiangsu Hansoh Pharmaceutical Group Co. Ltd.
Jiangsu Hansoh Pharmaceutical Co., Ltd. established in 1995, it ranks among the top 10 pharmaceutical manufactures of China, which is the leading anticancer API manufacturer in China. ? With strong R&D and Regulatory supports, All APIs and finished drugs got China SFDA GMP Certificate, two APIs got US FDA?and Japan PMDA approval, and one API got Korea KFDA approval. Recent years Jiangsu Hansoh focus on EU, US and Asia market and made great efforts. We are looking forward to promoting great cooperative relationships with customers from all over the world
Shamshree Lifesciences is a fast growing Indian pharmaceutical company engaged in manufacturing dry powder injectable products with focus on Carbapenems and Cephalosporins. Shamshree Lifesciences have world class and state-of-the-art facilities manufacturing a wide range of injectables. Our WHO GMP Certified plant comply with the Pharmaceutical Inspection Convention and Pharmaceutical Inspection Co-operation (PIC/S), U.S. Food and Drug Administration (U.S. FDA), Medicine and Healthcare products Regulatory Agency U.K. (MHRA U.K.), General Certificate of Conformity (G.C.C.), Agencia Nacional de Vigilancia Sanitaria (ANVISA Brazil), Instituto Nacional de Vigilancia de Medicamentos (INVIMA Colombia), Therapeutic Goods Administration (TGA Australia) etc.
Labiofam is one of the most successful companies in Cuba despite being 100 percent state-run. Its structure and working mechanisms are perfectly inserted in the economic changes taking place in the island. Labiofam is not only self-financing and reinvests its profits but contributes 40 percent of them to the state. In addition, it joined the South-South exchange politics that Havana encourages in its trade relations.Labiofam have 380 technologies, over 30 viral and bacterial vaccines for animal health, 21 diagnostics equipment, dietary supplements for human consumption, algae (spirulina), homeopathic medicine, disinfectants, toiletries and cleaning, starches for children with gluten intolerance , biofertilizers and biopesticides, probiotics, food (rice, beans, pork, eggs, lamb, rabbits), essential oils, fragrances for the French market.
Heber Biotec S. A.
Heber Biotec is a Cuban company that commercialize the final products, active principles, production technologies and R&D projects developed by the Center for Genetic Engineering in Havana, Cuba. In a few years, a small core of researchers peer into the complex world of new technologies, dominate it and create the present Centre for Genetic Engineering and Biotechnology (CIGB) of Havana, Cuba This Centre nowadays has facilities by 70,000 m2 and more than 1,100 workers, outfitted with the state of the art technology to run full projects since the idea to the product, from cloning and expressing in the lab to the industrial manufacturing and Marketing.
Parental Drugs India Limited
Parenteral Drugs (India) Limited (PDIL), a leading manufacturer of large volume parenteral is having 33 years of experience, in manufacturing. PDIL uses advanced aseptic processing technologies to minimize operator intervention and contamination risk in the filling and packaging of liquid parenteral drugs. One of these technologies is aseptic form-fill-seal (AFFS), in which a polymeric material is formed and sealed online to a container of choice, after the container is filled. Traditional parenteral filling and packaging requires 23 steps and individual machines for filling, stoppering and capping. In contrast FFS requires one piece of automated machinery and takes place in 6 seconds.